Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamina-G for Epigastric Pain After Gastric Biopsy
NCT04134364Phase 4Completed
- Sponsor
- Kyungpook National University Hospital
- Start
- Mar 2017
- Primary completion
- Aug 2019
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Sodium alginate in epigastric pain (2 arms), sponsored by Kyungpook National University Hospital. Primary endpoints: Gastrointestinal Symptom Rating Scale at Baseline at 0 days, Gastrointestinal Symptom Rating Scale within 24 hours and 1 more. Started Mar 2017; status: completed.
02
Drugs
Sodium alginate
03
Conditions
epigastric pain
Beyond the preview
Go deeper on NCT04134364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04134364.